A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*
Vincent, Jean-Louis, Artigas, Antonio, Petersen, Lars C., Meyer, ChristianVolume:
37
Language:
english
Journal:
Critical Care Medicine
DOI:
10.1097/ccm.0b013e31819fff2c
Date:
June, 2009
File:
PDF, 341 KB
english, 2009